Optimizing Mammographic Screening and Diagnosis of Breast Cancer
Raw data Time period being audited and the total number of examinations during that time Number of screening and number of diagnostic examinations and separate audit for each of these…
Raw data Time period being audited and the total number of examinations during that time Number of screening and number of diagnostic examinations and separate audit for each of these…
Individual from a family with a known deleterious BRCA1/BRCA2 mutation Personal history of breast cancerd + one or more of the following: Diagnosed at age ≤45 years Two breast primariese…
Fertility preservation options Standard strategy Ovarian stimulation required Invasive procedure required Male partner required Risk of malignant cells contamination Delay in cancer treatment Available in all centers Oocyte cryopreservation +…
Diagnosed at or before 45 years of age Having 2 breast primaries with one being diagnosed ≤50 years of age Diagnosed ≤50 years with at least 1 close relative with…
© Springer International Publishing Switzerland 2015Nicoletta Biglia and Fedro Alessandro Peccatori (eds.)Breast Cancer, Fertility Preservation and Reproduction10.1007/978-3-319-17278-1_1 1. Epidemiology of Breast Cancer in Young Women Fabio Parazzini1 , Antonella Villa1 , Giampiero Polverino1 , Stefania Noli1 and Giovanna Scarfone1 (1) Dipartimento di Scienze…
Time to subsequent pregnancy (months) Beta coefficient P value Hazard ratio (95 % CI) <6 0.79 0.579 2.20 (0.14–35.42) 6–24 −0.80 0.135 0.45 (0.16–1.28) >24 −0.74 0.009 0.48 (0.27–0.83) (Each…
© Springer International Publishing Switzerland 2015Nicoletta Biglia and Fedro Alessandro Peccatori (eds.)Breast Cancer, Fertility Preservation and Reproduction10.1007/978-3-319-17278-1_5 5. Breast Cancer During Pregnancy Giovanni Codacci-Pisanelli1, 2 , Giovanna Scarfone3 , Lino Del Pup4 , Eleonora Zaccarelli2 and Fedro A. Peccatori1 (1) Fertility and Procreation Unit, European…
Trial Patient population characteristics Study design Median follow-up DFS (HR, 95 % CI) OS (HR, 95 % CI) ABCSG-12 [94, 96] 1,803 premenopausal women. No adjuvant chemotherapy Median age 45…
Age Annual incidence <20 0.1/100,000 20–24 1.4/100,000 25–29 8.1/100,000 30–34 24.8/100,000 35–39 58.4/100,000 40–44 116.1/100,000 Modified by Pagani and Goldhirsh (2000) [6] Young age, even after adjustment for socio-demographic and…
(1) Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Introduction Definition of Second Primary Cancer Incidence Patterns Mechanisms Genetic Predisposition Lifestyle,…